Page 2 - மார்க் பெர்த்தியாம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Health Canada is updating warning labels on AstraZeneca COVID-19 vaccines after concluding that rare but severe blood clots may be linked to use of the vaccine. A woman in Quebec developed a blood clot after immunization with AstraZeneca’s Covishield vaccine, Canadian health authorities revealed Tuesday. This was the country’s first domestic report of a clot following immunization with AstraZeneca’s vaccine. Health officials were already investigating reports of similar clots happening in Europe. The Quebec woman was over age 55 and did not have other risk factors for developing a clot, according to Dr. Supriya Sharma, chief medical adviser with Health Canada, who spoke at a news conference Wednesday. The woman is now recovering at home.

Marc berthiaumeAstrazeneca covishieldSupriya sharmaHealth canadaBureau of medical scienceMedical scienceமார்க் பெர்த்தியாம்சுப்ரியா ஷர்மாஆரோக்கியம் கனடாபணியகம் ஆஃப் மருத்துவ அறிவியல்மருத்துவ அறிவியல்